TU Dresden

What happens in the body of ALS patients?
Scientists from TU Dresden find ways to reduce the number of dying neurons and search for therapeutic approaches to treat ALS   Amyotrophic lateral sclerosis (ALS) is an incurable... [read more]
Registration open for the 13th CRTD Summer Conference
Register now and save the date [read more]
© Thomas Schlorke
Girls' Day 2019
Future prospects for girls at the CRTD and the fascinating, regenerating zebrafish. [read more]
CRTD research featured on the cover of EMBO Journal is highlighted by the scientific community
The group of Prof. Federico Calegari shows that boosting stem cells gives extra neurons to the brain and turns ordinary mice into “super-smellers”. [read more]
Cover of EMBO Journal
UniStem Day 2019
Participation in international action day on stem cell research [read more]
A new generation of focused future thinkers
Researchers from TU Dresden discover protein for more mobility [read more]
Prof. Dr. Martina Rauner and Dr. Ulrike Baschant © Stephan Wiegand
Prof. Michael Brand is the new institute director of the CRTD
Prof. Dr. Michael Brand is the new Director of the Center for Regenerative Therapies (CRTD) at TU Dresden. [read more]
Prof. Ezio Bonifacio, PhD & Prof. Dr. Michael Brand © CRTD
Knowledge builds bridges: Duke of Kent visits TU Dresden
Today (11th February 2019), Technische Universität Dresden (TUD) welcomed His Royal Highness Prince Edward, Duke of Kent. [read more]
© Marc Eisele/Universitätsklinikum Dresden

Research at the Center for Regenerative Therapies (CRTD) at TU Dresden focuses on discovering principles of cell and tissue regeneration, and leveraging this for recognition, treatment, and reversal of diseases. The CRTD is well positioned for this challenge with its diversity in model organisms, organs, and disease systems and its range of methodological approaches from basic research to validation projects and clinical studies. The CRTD links the bench to the clinic, and scientists to clinicians to bring expertise in stem cells, gene-editing, and regeneration towards innovative therapies for metabolic, osteo-hematological, and neurological diseases.